STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial-Reference-Cited by-同舟云学术

STereotactic Ablative RadioTherapy in NEWly Diagnosed and Recurrent Locally Advanced Non-Small Cell Lung Cancer Patients Unfit for ConcurrEnt RAdio-Chemotherapy: Early Analysis of the START-NEW-ERA Non-Randomised Phase II Trial

Published:2023-03 Issue:4 Volume:115 Page:886-896
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Arcidiacono Fabio,Anselmo Paola,Casale Michelina,Zannori Cristina,Ragusa Mark,Mancioli Francesco,Marchetti Giovanni,Loreti Fabio,Italiani Marco,Bracarda Sergio,Maranzano Ernesto,Trippa Fabio

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference51 articles.

1. Trends in stage distribution for patients with non-small cell lung cancer: A National Cancer Database survey;Morgensztern;J Thoracic Oncol,2010

2. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans;Wang;J Clin Oncol,2012

3. Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer;Antonia;N Engl J Med,2017

4. Five-year survival outcomes from the PACIFIC trial: Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Spigel;J Clin Oncol,2022

5. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: A prospective, population-based study;De Ruysscher;Ann Oncol,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-07

2. Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors;Cancer Communications;2024-06-05

3. Dosimetric Analysis of Proximal Bronchial Tree Subsegments to Assess The Risk of Severe Toxicity After Stereotactic Body Radiation Therapy of Ultra-central Lung Tumors;Clinical and Translational Radiation Oncology;2024-03

4. Efficacy and toxicity of stereotactic body radiotherapy for un-resectable stage III non-small cell lung cancer patients unfit for concurrent chemoradiation therapy: a retrospective study;Radiation Oncology;2023-08-24

5. 18F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial;Radiotherapy and Oncology;2023-08